| Literature DB >> 30797902 |
Juntaek Oh1, Jun Xu1, Jenny Chong1, Dong Wang2.
Abstract
Transcription, catalyzed by RNA polymerase II (Pol II) in eukaryotes, is the first step in gene expression. RNA Pol II is a 12-subunit enzyme complex regulated by many different transcription factors during transcription initiation, elongation, and termination. During elongation, Pol II encounters various types of obstacles that can cause transcriptional pausing and arrest. Through decades of research on transcriptional pausing, it is widely known that Pol II can distinguish between different types of obstacles by its active site. A major class of obstacles is DNA lesions. While some DNA lesions can cause transient transcriptional pausing, which can be bypassed by Pol II itself or with the help from other elongation factors, bulky DNA damage can cause prolonged transcriptional pausing and arrest, which signals for transcription coupled repair. Using biochemical and structural biology approaches, the outcomes of many different types of DNA lesions, DNA modifications, and DNA binding molecules to transcription were studied. In this mini review, we will describe the in vitro transcription assays with Pol II to investigate the impacts of various DNA lesions on transcriptional outcomes and the crystallization method of lesion-arrested Pol II complex. These methods can provide a general platform for the structural and biochemical analysis of Pol II transcriptional pausing and bypass mechanisms. Published by Elsevier Inc.Entities:
Keywords: DNA lesion; RNA polymerase II; Transcription; X-ray crystallography
Mesh:
Substances:
Year: 2019 PMID: 30797902 PMCID: PMC6589100 DOI: 10.1016/j.ymeth.2019.02.019
Source DB: PubMed Journal: Methods ISSN: 1046-2023 Impact factor: 3.608